The Chemours Company · 20 hours ago
Financial Analyst - Corporate Decision Support
The Chemours Company is seeking a Financial Analyst to join their Corporate Decision Support team. This role involves providing financial support to various groups within the company and performing analyses related to environmental reserve projects.
ChemicalMedicalMedical Device
Responsibilities
Provide financial support to the Corporate Remediation Group, Legacy Litigation Group, and the Memorandum of Understanding (MOU) Process
Support the quarterly consolidation process of the environmental reserve project estimates
Run the monthly environmental reserve spend report and reconcile ENFOS (project management software system) to spend report
Complete project spend and environmental reserve variance analysis
Assist in preparing monthly forecasts and the annual budgets
Assist in the coordination and reconciliation process of the MOU billing process between DuPont, Corteva, and Chemours
Perform ad hoc financial analysis and special projects as needed
Qualification
Required
Degree in Finance, Accounting, or Economics
1+ year of finance, accounting, or business analysis experience
Understanding of the 3 financial statements (i.e. Balance Sheet, Income Statement, Statement of Cash Flows) and their interaction
Ability to work independently as well as part of a team
Strong oral, written and interpersonal skills
Proficiency in Excel, Power BI, PowerPoint, and SAP
Preferred
Public Accounting or Environmental Accounting Experience is a PLUS
Benefits
Competitive Compensation
Comprehensive Benefits Packages
401(k) Match
Employee Stock Purchase Program
Tuition Reimbursement
Commuter Benefits
Learning and Development Opportunities
Strong Inclusion and Diversity Initiatives
Company-paid Volunteer Day
Company
The Chemours Company
Every day Chemours delivers Trusted Chemistry that enables products and technologies that people rely on to live better and thrive.
Funding
Current Stage
Public CompanyTotal Funding
$660MKey Investors
US Department of Energy
2024-11-13Post Ipo Debt· $600M
2024-03-20Grant· $60M
2015-07-01IPO
Leadership Team
Recent News
Bizjournals.com Feed (2025-11-12 15:43:17)
2026-01-07
Sports Business Journal
2025-11-15
Company data provided by crunchbase